In the INDI-UTI study, eligible children were between 3 months and 12 years of age, were febrile (≥38°C) at the time of or within 24 hours preceding the start of treatment, and had growth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback